,
Dures, Emma
Hewlett, Sarah
Lord, Jane
Bowen, Clive
McHugh, Neil
Tillett, William
Funding for this research was provided by:
Programme Grants for Applied Research (RP-PG-1212-20007)
Article History
First Online: 22 February 2017
Change Date: 23 March 2019
Change Type: Correction
Change Date: 23 March 2019
Change Type: Correction
Change Details: The Open Access license, which previously read.
Change Details: The Open Access license, which previously read.
Compliance with ethical standards
:
: Emma Dures, Sarah Hewlett, Jane Lord, Clive Bowen, Neil McHugh and William Tillett declare no conflicts of interest relevant to the contents of this article. Emma Dures, Sarah Hewlett, William Tillett and Neil McHugh have contributed to the field of patient-reported outcomes and outcome measurement, and have been involved in the OMERACT initiative at some point.
: The authors received no specific funding for this manuscript and have no financial disclosures directly linked with the contents of this paper.
: This report is independent research funded by the National Institute for Health Research (Programme Grants for Applied Research, Early detection to improve outcome in patients with undiagnosed psoriatic arthritis [‘PROMPT’], RP-PG-1212-20007). The views expressed in this publication are those of the authors and do not necessarily reflect the views of the National Health Service, the National Institute for Health Research or the Department of Health.